Day: January 4, 2025

COLUMBIA, Md., Jan. 04, 2025 (GLOBE NEWSWIRE) — It is with profound sadness that Tenable Holdings, Inc. announces the passing of our Chairman and Chief Executive Officer, Amit Yoran. Amit passed away unexpectedly yesterday. He had been battling cancer. A visionary leader and a pioneer in the cybersecurity industry, Amit dedicated his life to making the digital world safer. His unwavering commitment to innovation and relentless pursuit of excellence transformed Tenable into a global leader in exposure management. His contributions to the field have left an indelible mark, not only on the company but on the broader cybersecurity community. “Amit was an extraordinary leader, colleague, and friend,” said Art Coviello, Tenable’s lead independent director. “His passion for cybersecurity, his strategic vision, and his ability to inspire...

VANCOUVER, British Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) — Mustang Energy Corp. (CSE: MEC, OTC: MECPF, FRA:92T) (the “Company” or “Mustang”) is pleased to share a summary of its accomplishments since the commencement of trading in mid-2024. The Company has made significant strides in its mission to develop high-potential uranium and critical mineral assets in the Athabasca Basin, Saskatchewan, solidifying its position as a growing leader in the resource exploration sector. Key Highlights of 2024:Land Acquisitions: Expanded land holdings to an impressive 77,318 hectares, strategically located in and around the Athabasca Basin, a notable uranium district. Capital Raised: Successfully secured over $4.2 million in gross proceeds, providing a robust financial foundation for ongoing and upcoming 2025 operations. Exploration Advancements:...

IRVINE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) — AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar pathway, today announced that it has commenced a public offering (the “Offering”) to offer and sell units, consisting of (i) shares of Common Stock (or pre-funded warrants in lieu thereof) and (ii) warrants to purchase shares of Common Stock. In addition, the Company expects to grant Aegis Capital Corp. a 45-day option to purchase additional shares of Common Stock representing up to 15% of the total shares of Common Stock sold in the Offering solely to cover over-allotments, if any. The Company intends to use the net proceeds from the Offering for general corporate and working capital needs. The Company’s...